Otlang, Aimee .
HRN: 23-95-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
CEFUROXIME 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
BID
THICKLY MSAF
Checking Final Appropriateness
10/24/2023
METRONIDAZOLE 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
TID
THICKLY MSAF
Checking Final Appropriateness